{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:28:14Z","timestamp":1786768094507,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013949","name":"Dana Ilmu Pengetahuan Indonesia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014538","name":"Lembaga Pengelola Dana Pendidikan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.actatropica.2026.108265","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:03:21Z","timestamp":1785510201000},"page":"108265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-SARS-CoV-2 receptor-binding domain IgG titers and associated factors after heterologous mRNA booster vaccination in individuals primed with the inactivated vaccine"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7630-8413","authenticated-orcid":false,"given":"Harapan","family":"Harapan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianisah Putri","family":"Ayulinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qatrunnada","family":"Kamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3165-2151","authenticated-orcid":false,"given":"Samsul","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imelda","family":"Maelani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7851-7747","authenticated-orcid":false,"given":"Fitdha","family":"Khairadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8903-9977","authenticated-orcid":false,"given":"Ichsan","family":"Ichsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8396-6051","authenticated-orcid":false,"given":"Agung","family":"Pranata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunita","family":"Arliny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimun","family":"Syukri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudatsir","family":"Mudatsir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2026.108265_bib0001","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(22)01656-7","article-title":"Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales","volume":"400","author":"Agrawal","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2026.108265_bib0002","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.etap.2015.09.020","article-title":"The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology","volume":"40","author":"Ahn","year":"2015","journal-title":"Env. Toxicol. Pharmacol."},{"key":"10.1016\/j.actatropica.2026.108265_bib0003","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.180750","article-title":"Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases","volume":"9","author":"Anderson","year":"2024","journal-title":"JCI. Insight."},{"key":"10.1016\/j.actatropica.2026.108265_bib0004","article-title":"Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required","author":"Balkan","year":"2022","journal-title":"Ir. J. Med. Sci. 192(1), 19\u201325"},{"key":"10.1016\/j.actatropica.2026.108265_bib0005","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2026.108265_bib0006","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra2206573","article-title":"Covid-19 vaccines - immunity, variants, boosters","volume":"387","author":"Barouch","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.actatropica.2026.108265_bib0007","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3390\/vaccines12111284","article-title":"Factors predicting COVID-19 vaccine effectiveness and longevity of humoral immune responses","volume":"12","author":"Berber","year":"2024","journal-title":"Vaccines"},{"issue":"1992","key":"10.1016\/j.actatropica.2026.108265_bib0008","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1590\/1806-9282.20221074","article-title":"Evaluation and follow-up of antibody formation after CoronaVac vaccine","volume":"68","author":"\u00c7ali\u015fir","year":"2022","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.actatropica.2026.108265_bib0009","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41591-022-01739-w","article-title":"Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial","volume":"28","author":"Chu","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.actatropica.2026.108265_bib0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41577-021-00550-x","article-title":"Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection","volume":"21","author":"Cromer","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actatropica.2026.108265_bib0011","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/vaccines10091548","article-title":"Antibody titers and protection against Omicron (BA.1 and BA.2) SARS-CoV-2 infection","volume":"10","author":"Dimeglio","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.actatropica.2026.108265_bib0012","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jinf.2022.08.040","article-title":"Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population","volume":"85","author":"Dimeglio","year":"2022","journal-title":"J. Infect."},{"key":"10.1016\/j.actatropica.2026.108265_bib0013","article-title":"Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity","volume":"9","author":"D'Souza","year":"2024","journal-title":"NPJ. Vaccin."},{"key":"10.1016\/j.actatropica.2026.108265_bib0014","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/jmv.27485","article-title":"Host factors and vaccine efficacy: implications for COVID-19 vaccines","volume":"94","author":"Falahi","year":"2022","journal-title":"J. Med. Virol."},{"issue":"585\u2013600","key":"10.1016\/j.actatropica.2026.108265_bib0015","article-title":"The effects of obesity and metabolic abnormalities on severe COVID-19-related outcomes after vaccination: a population-based study","volume":"35","author":"Fan","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.actatropica.2026.108265_bib0016","doi-asserted-by":"crossref","DOI":"10.3201\/eid2806.220061","article-title":"Dynamics of SARS-CoV-2 antibody response to CoronaVac followed by booster dose of BNT162b2 vaccine","volume":"28","author":"Fonseca","year":"2022","journal-title":"Emerg. Infect. Dis. J."},{"key":"10.1016\/j.actatropica.2026.108265_bib0017","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/oby.21383","article-title":"Obesity decreases B cell responses in young and elderly individuals","volume":"24","author":"Frasca","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/j.actatropica.2026.108265_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245424","article-title":"Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients","volume":"16","author":"Frasca","year":"2021","journal-title":"PLoS. One"},{"key":"10.1016\/j.actatropica.2026.108265_bib0019","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/oby.21003","article-title":"Adipose tissue as an immunological organ","volume":"23","author":"Grant","year":"2015","journal-title":"Obesity"},{"key":"10.1016\/j.actatropica.2026.108265_bib0020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.12688\/f1000research.109676.2","article-title":"Waning Anti-SARS-CoV-2 neutralizing antibody in CoronaVac-vaccinated individuals in Indonesia","volume":"11","author":"Harapan","year":"2023","journal-title":"F1000Res"},{"key":"10.1016\/j.actatropica.2026.108265_bib0021","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.orcp.2020.07.002","article-title":"Obesity and mortality of COVID-19. Meta-analysis","volume":"14","author":"Hussain","year":"2020","journal-title":"Obes. Res. Clin. Pr."},{"key":"10.1016\/j.actatropica.2026.108265_bib0022","series-title":"Penambahan Regimen Vaksinasi COVID-19 Dosis Lanjutan (Booster)","year":"2022"},{"key":"10.1016\/j.actatropica.2026.108265_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10050639","article-title":"Dynamics of neutralizing antibody and T-cell responses to SARS-CoV-2 and variants of concern after primary immunization with CoronaVac and booster with BNT162b2 or ChAdOx1 in health care workers","volume":"10","author":"Jantarabenjakul","year":"2022","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.actatropica.2026.108265_bib0024","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3390\/vaccines9101145","article-title":"Rapidly declining SARS-CoV-2 antibody titers within 4 months after BNT162b2 vaccination","volume":"9","author":"Jo","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.actatropica.2026.108265_bib0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/vaccines10010086","article-title":"Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccine","volume":"10","author":"Kanokudom","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.actatropica.2026.108265_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11030570","article-title":"The fourth dose of mRNA COVID-19 vaccine following 12 different three-dose regimens: safety and immunogenicity to omicron BA.4\/BA.5","volume":"11","author":"Kanokudom","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.actatropica.2026.108265_bib0027","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1159\/000525555","article-title":"Risk factors influencing seroconversion after inactive SARS-CoV-2 vaccination in people living with obesity","volume":"15","author":"Kara","year":"2022","journal-title":"Obes. Fact."},{"key":"10.1016\/j.actatropica.2026.108265_bib0028","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000530315","article-title":"Antibody response to inactive SARS-CoV-2 vaccination in a cohort of elderly patients living with obesity","volume":"16","author":"Kara","year":"2023","journal-title":"Obes. Fact."},{"key":"10.1016\/j.actatropica.2026.108265_bib0029","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1007\/s11695-022-06181-y","article-title":"Antibody response to SARS-CoV-2 vaccines in people with severe obesity","volume":"32","author":"Kara","year":"2022","journal-title":"Obes. Surg."},{"key":"10.1016\/j.actatropica.2026.108265_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32321-0","article-title":"Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens","volume":"13","author":"Klemis","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actatropica.2026.108265_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105556","article-title":"Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta\/Omicron variants following an inactivated whole-virus vaccine","volume":"212","author":"Lu","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.actatropica.2026.108265_bib0032","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/oby.23353","article-title":"Antibody responses to BNT162b2 mRNA vaccine: infection-na\u00efve individuals with abdominal obesity warrant attention","volume":"30","author":"Malavazos","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/j.actatropica.2026.108265_bib0033","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01162-21","article-title":"Differences in IgG antibody responses following BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines","volume":"9","author":"Montoya","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.actatropica.2026.108265_bib0034","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-29686-9","article-title":"Immune responses after two inactivated COVID-19 vaccine doses, a heterologous third dose and subsequent boosting with bivalent mRNA in adults","volume":"15","author":"Muangnoicharoen","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2026.108265_bib0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s42269-022-00787-z","article-title":"COVID-19 vaccines: their effectiveness against the severe acute Respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants","volume":"46","author":"Noor","year":"2022","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.actatropica.2026.108265_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1287388","article-title":"SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients","volume":"14","author":"Onyango","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2026.108265_bib0037","article-title":"Antibody responses to COVID-19 vaccination in people with obesity: a systematic review and meta-analysis","volume":"17","author":"Ou","year":"2023","journal-title":"Influenza Other Respir. Virus."},{"key":"10.1016\/j.actatropica.2026.108265_bib0038","doi-asserted-by":"crossref","first-page":"1012526","DOI":"10.3389\/fimmu.2022.1012526","article-title":"Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2","volume":"13","author":"\u00d6zbay Kurt","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2026.108265_bib0039","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.vaccine.2015.06.101","article-title":"The weight of obesity on the Human immune response to vaccination","volume":"33","author":"Painter","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2026.108265_bib0040","article-title":"Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships","volume":"21(11), e13128","author":"Popkin","year":"2020","journal-title":"Obes. Rev."},{"key":"10.1016\/j.actatropica.2026.108265_bib0041","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41591-021-01548-7","article-title":"Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK","volume":"27","author":"Pouwels","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.actatropica.2026.108265_bib0042","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-06837-0","article-title":"Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters","volume":"23","author":"Pradenas","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.actatropica.2026.108265_bib0043","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apha.12246","article-title":"Adipose tissue and its role in organ crosstalk","volume":"210","author":"Romacho","year":"2014","journal-title":"Acta Physiol."},{"key":"10.1016\/j.actatropica.2026.108265_bib0044","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02321-z","article-title":"Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis","volume":"11","author":"Rotshild","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2026.108265_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.155121","article-title":"Obesity, metabolic phenotypes and COVID-19","volume":"128","author":"Sanoudou","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.actatropica.2026.108265_bib0046","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/idr13040084","article-title":"COVID-19 vaccine booster: to boost or not to boost","volume":"13","author":"Shekhar","year":"2021","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.actatropica.2026.108265_bib0047","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/oby.23208","article-title":"The association between obesity and peak antibody titer response in COVID-19 infection","volume":"29","author":"Soffer","year":"2021","journal-title":"Obesity"},{"key":"10.1016\/j.actatropica.2026.108265_bib0048","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/jama.2021.15125","article-title":"Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273","volume":"326","author":"Steensels","year":"2021","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.actatropica.2026.108265_bib0049","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/s41591-023-02343-2","article-title":"Accelerated waning of the humoral response to COVID-19 vaccines in obesity","volume":"29","author":"Van der Klaauw","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.actatropica.2026.108265_bib0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/vaccines10010079","article-title":"Rapid weight loss, central obesity improvement and blood glucose reduction are associated with a stronger adaptive immune response following COVID-19 mRNA vaccine","volume":"10","author":"Watanabe","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.actatropica.2026.108265_bib0051","unstructured":"WHO, 2000. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communication Australia. Available from: http:\/\/iris.wpro.who.int\/handle\/10665.1\/5379. Accessed date: 1 Dec 2022."},{"key":"10.1016\/j.actatropica.2026.108265_bib0052","unstructured":"WHO, 2026. WHO COVID-19 dashboard. Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases. Accessed date: 25 March 2026."},{"key":"10.1016\/j.actatropica.2026.108265_bib0053","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S2213-2600(23)00015-2","article-title":"Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December 2022","volume":"11","author":"Wu","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.actatropica.2026.108265_bib0054","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3390\/vaccines11071184","article-title":"SARS-CoV-2 antibody dynamics after COVID-19 vaccination and infection: a real-world cross-sectional analysis","volume":"11","author":"Yorsaeng","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.actatropica.2026.108265_bib0055","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"10","author":"Zatterale","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.actatropica.2026.108265_bib0056","article-title":"Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): a cross-sectional and cohort study in Zhejiang, China","volume":"12","author":"Zhang","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.actatropica.2026.108265_bib0057","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30340-5","article-title":"Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant","volume":"13","author":"Zuo","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X26002986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X26002986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:02:16Z","timestamp":1786766536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X26002986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":57,"alternative-id":["S0001706X26002986"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2026.108265","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-SARS-CoV-2 receptor-binding domain IgG titers and associated factors after heterologous mRNA booster vaccination in individuals primed with the inactivated vaccine","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2026.108265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108265"}}